1,052 filings
Page 12 of 53
SC 13G
EYPT
EyePoint Pharmaceuticals Inc
3 Feb 22
EyePoint Pharmaceuticals / FRANKLIN RESOURCES ownership change
2:12pm
SC 13G/A
EYPT
EyePoint Pharmaceuticals Inc
3 Feb 22
EyePoint Pharmaceuticals / FRANKLIN RESOURCES ownership change
2:02pm
3
EYPT
EyePoint Pharmaceuticals Inc
14 Jan 22
EyePoint Pharmaceuticals / Michael Craig Pine ownership change
2:47pm
4
Michael Craig Pine
14 Jan 22
EyePoint Pharmaceuticals / Michael Craig Pine ownership change
2:14pm
8-K/A
EYPT
EyePoint Pharmaceuticals Inc
12 Jan 22
Other Events
4:02pm
8-K
EYPT
EyePoint Pharmaceuticals Inc
10 Jan 22
EyePoint Pharmaceuticals Appoints Michael C. Pine as Chief Corporate Development and Strategy Officer
4:31pm
8-K
EYPT
EyePoint Pharmaceuticals Inc
10 Jan 22
EyePoint Pharmaceuticals Announces 2022 Clinical Plans and Highlights Recent Corporate and Clinical Achievements
8:06am
8-K
EYPT
EyePoint Pharmaceuticals Inc
10 Dec 21
EyePoint Pharmaceuticals and Harrow Health’s ImprimisRx Announce Expanded
4:01pm
8-K
EYPT
EyePoint Pharmaceuticals Inc
19 Nov 21
EyePoint Pharmaceuticals Announces Proposed Public Offering of Common Stock
4:01pm
424B5
EYPT
EyePoint Pharmaceuticals Inc
18 Nov 21
Prospectus supplement for primary offering
5:13pm
4
EYPT
EyePoint Pharmaceuticals Inc
17 Nov 21
EyePoint Pharmaceuticals / Nancy Lurker ownership change
5:03pm
FWP
EYPT
EyePoint Pharmaceuticals Inc
17 Nov 21
Free writing prospectus
6:09am
424B5
EYPT
EyePoint Pharmaceuticals Inc
16 Nov 21
Prospectus supplement for primary offering
5:13pm
8-K
EYPT
EyePoint Pharmaceuticals Inc
15 Nov 21
Other Events
6:50am
10-Q
2021 Q3
EYPT
EyePoint Pharmaceuticals Inc
Quarterly report
5 Nov 21
11:30am
4
David Scott Jones
3 Nov 21
EyePoint Pharmaceuticals / David Scott Jones ownership change
5:54pm
4
EYPT
EyePoint Pharmaceuticals Inc
3 Nov 21
EyePoint Pharmaceuticals / Jay S. Duker ownership change
5:50pm
3
EYPT
EyePoint Pharmaceuticals Inc
3 Nov 21
EyePoint Pharmaceuticals / Jay S. Duker ownership change
5:48pm
8-K
EYPT
EyePoint Pharmaceuticals Inc
3 Nov 21
EyePoint Pharmaceuticals Reports Third Quarter 2021 Financial Results and Highlights Recent Corporate Developments
7:05am
8-K
EYPT
EyePoint Pharmaceuticals Inc
1 Nov 21
EyePoint Pharmaceuticals Appoints
7:05am